Piermont Capital Management »

Anika Therapeutics shares owned by Piermont Capital Management

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Piermont Capital Management from 13F filings

Historical chart of Piermont Capital Management investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Piermont Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Piermont Capital Management

Quarter filed Position value Share count Share price at filing
2018-12-31 $1.3M 40k 33.62
2018-09-30 $1.7M 39k 42.17
2018-06-30 $1.4M 45k 32.00
2018-03-31 $2.2M 43k 49.72
2017-12-31 $2.1M 38k 53.91
2017-09-30 $2.3M 40k 58.01
2017-06-30 $2.0M 40k 49.34
2017-03-31 $2.2M 50k 43.44
2016-12-31 $2.6M 54k 48.96
2016-09-30 $2.7M 57k 47.85
2016-06-30 $4.3M 81k 53.65
2016-03-31 $613k 14k 44.74
2015-12-31 $534k 14k 38.14
2015-09-30 $485k 15k 31.82
2015-06-30 $503k 15k 33.01
2015-03-31 $648k 16k 41.17
2014-12-31 $423k 10k 40.75
2014-09-30 $386k 11k 36.69
2014-06-30 $270k 5.8k 46.31
2014-03-31 $240k 5.8k 41.17
2013-12-31 $222k 5.8k 38.08